Participating Institutions
Kelly Frazer, Ph.D., director of genomics research at Scripps Translational Science Institute in San Diego, is working on an integrated Omics Program that studies the intersection of genomics, proteomics, and glycomincs and their influence on disease. She is researching how a piece of chromosome 9 (called 9p21) contributes to heart disease.
The Scripps Translational Science Institute
La Jolla, CA
Visit SitePrincipal Investigator: Eric J. Topol, M.D.
Participating Institutions and Community Partners:
- The Neurosciences Institute
- J Craig Venter Institute
- San Diego Supercomputer Center
- Genomics Institute of the Novartis Research Foundation
- Salk Institute
- The Center for Applied Genomics at Children's Hospital of Philadelphia
- San Diego State University
- Burnham Institute
- Whittier Institute
- Scripps Clinic Medical Group
- County of San Diego Free Clinics
- Community Health Improvement Partners
- San Diego Border Area Health Education Center
- Chula Vista Family Health Center
- Southeast San Diego Elementary Schools
- Retinal Consulting Services
- Indian Health Council
- 15 Community Health Centers
- 25 San Diego Area Life Science Companies
Highlights:
The Scripps Translational Science Institute (STSI) will emphasize three dimensions of translation: traditional bench to bedside, bedside to bench and back to bedside, and bedside to the community and practice of medicine. The vision of this program provides the appropriate amalgam of "integration and innovation" and opportunity to capitalize on particular strengths at The Scripps Research Institute, Scripps Health, and partnering institutions and faculty members that have led to the development of the goals of the STSI. Building upon and establishing specific collaborations with leading translational science and clinical investigators will accelerate discovery that has impact across multiple research disciplines. Collaborations with a large subset of the 550 life science companies in San Diego provide an extraordinary advantage for accessing innovative technology and catalyzing benefits to patients. STSI exploits the excitement of today's scientific advances to advance tomorrow's preventions, betterment of health, and the training of the future leaders of academic medicine.